Chemicals company DSM has made a $1bn offer for US company Martek Biosciences.
The cash deal has been recommended by both companies’ boards and is expected to be finalised by February.
The deal represents ‘the first major acquisition by DSM after its successful transformation into a Life Sciences and Materials Sciences company,’ DSM said in a statement.
The two companies already work together. Martek is particularly strong in the field of • polyunsaturated fatty acids (PUFAs), nutrition ingredients, especially in infant formula.
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.Make a donation